Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/22/2010CN1849136B Cancerous disease modifying antibodies
12/22/2010CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof
12/22/2010CN101925612A Antibodies against cancer-associated epitope of variant nfkbib and uses thereof
12/22/2010CN101925611A Wise binding agents and epitopes
12/22/2010CN101925364A 14-3-3 antagonists for prevention and treatment of arthritis
12/22/2010CN101925363A Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
12/22/2010CN101921802A Recombination BCG vaccine rBCG::AB
12/22/2010CN101921801A Recombinant BCG vaccine rBCG::X
12/22/2010CN101921787A schistosoma japonica adenosine deaminase gene and coding protein and application thereof
12/22/2010CN101921783A Schistosoma japonica L-lactic dehydrogenase gene, encoding protein and application thereof
12/22/2010CN101921782A Schistosoma japonica arginyl transport RNA enzyme gene, encoding protein and application thereof
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921768A Schistosoma japonica 14-3-3 protein gene, coded protein thereof and application thereof
12/22/2010CN101921767A Schistosoma japonica MF3 protein gene, and coding protein and application thereof
12/22/2010CN101921733A Preparation method and application of Qbeta-2aa phage virus-like particle protein
12/22/2010CN101921732A A virus causing respiratory tract illness in susceptible mammals
12/22/2010CN101921726A Oral transformant for immunizing and blocking chicken inhibin and application thereof
12/22/2010CN101921725A Converter for inhibiting hen somatostatin action through oral immunization and application thereof
12/22/2010CN101921324A Alba plastein C9orf23 protein of human and use in self autoimmune hepatitis diagnosis
12/22/2010CN101921323A Human protein (ribosomal protein S20) and use thereof in diagnosis of autoimmune hepatitis
12/22/2010CN101921310A Dengue virus (DENV) specific HLA-A2 (Human Leukocyte Antigen-A2) restrictive epitope peptide and application thereof
12/22/2010CN101920021A Immune-enhanced hepatitis B therapeutic multivalent vaccine and preparation method thereof
12/22/2010CN101920015A Pharmaceutical composition for cancer treatment
12/22/2010CN101920014A Animal and plant attenuated AIDS vaccine
12/22/2010CN101920013A Veterinary rabies vaccine and method for preparing same
12/22/2010CN101920012A Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof
12/22/2010CN101920011A Recombination attenuated salmonella typhimurium carrier vaccine of expression IBDV (Infectious Bursal Disease Virus) immunogenic gene and preparation method thereof
12/22/2010CN101920010A Recombinant attenuation salmonella typhimurium vector vaccine expressing PRRSV (Porcine Reproductive and Respiratory Syndrome Virus) immunogen gene and preparation method thereof
12/22/2010CN101920009A Vaccine for preventing and curing tumor
12/22/2010CN101920008A Preparation containing Abeta 40 polypeptide and aluminum adjuvant and method for purifying Abeta 40 polypeptide
12/22/2010CN101920006A Cyclin Y and use thereof
12/22/2010CN101920004A Preparation and application of coconut globulin ferrous complex iron supplement agent
12/22/2010CN101402944B EV-71 virus seed, inactivated vaccine for human and method of producing the same
12/22/2010CN101314619B Tumour treatment vaccine CTP37CRM197 immunogen, preparation method and application thereof
12/22/2010CN101254301B Preparation of HSP65 recombination protein and use thereof
12/22/2010CN101095951B Therapeutic HBV DNA vaccines, method for preparing the same and application thereof
12/21/2010US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy
12/21/2010US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis
12/21/2010US7855276 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells
12/21/2010US7855272 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides
12/21/2010US7855271 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants
12/21/2010US7855183 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
12/21/2010US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors
12/21/2010US7855076 Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway
12/21/2010US7855064 Recombinant Listeria strain comprising integrated nucleic acid molecule having two open reading frames expressing heterologous antigen and metabolic enzyme
12/21/2010US7855056 Antibody against tumor specific antigen as target
12/21/2010US7855052 sequences from the Core/E1 region of HCV type 3; detection of HCV infection
12/21/2010US7854942 Anti-gluten egg yolk antibodies for the treatment of celiac disease
12/21/2010US7854937 Flavivirus fusion inhibitors
12/21/2010US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010US7854932 Immunogenic compositions comprising progastrin and uses thereof
12/21/2010US7854931 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
12/21/2010US7854930 Anti-igf-ir antibodies and uses thereof
12/21/2010US7854717 uses ultrapheresis, refined to remove compounds of less than 120,000 daltons molecular weight, followed by administration of replacement fluid, to stimulate the patient's immune system to attack solid tumors
12/21/2010CA2457145C Assay method for alzheimer's disease
12/21/2010CA2434337C Combination of probiotics
12/21/2010CA2387182C Lentiviral vectors for the preparation of immunotherapeutical compositions
12/21/2010CA2351836C Glycosphingolipid
12/21/2010CA2329138C Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2260273C Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
12/21/2010CA2199821C Cloning and regulation of an endothelial cell protein c/activated protein c receptor
12/19/2010CA2670301A1 Inhibition of metastasis using activated protein c
12/16/2010WO2010144908A2 Mammalian genes involved in tularemia and other infections
12/16/2010WO2010144797A2 Influenza vaccines with enhanced immunogenicity and uses thereof
12/16/2010WO2010144734A1 Benzonaphthyridine-containing vaccines
12/16/2010WO2010144711A2 Immunological targeting of pathological tau proteins
12/16/2010WO2010144602A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
12/16/2010WO2010144295A1 Aptamer-targeted costimulatory ligand aptamer
12/16/2010WO2010144140A2 Egfr and par2 regulation of intestinal permeability
12/16/2010WO2010143435A1 Vaccine therapy for choroidal neovascularization
12/16/2010WO2010143194A1 Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof
12/16/2010WO2010142997A1 Use of a serum composition to reduce the levels of tnf and/or vegf in mammals
12/16/2010WO2010142996A1 Therapeutic agent and assay
12/16/2010WO2010142686A1 Immunogenic compositions having low sodium chloride concentration
12/16/2010WO2010142685A1 Adjuvant compositions comprising a non-ionic isotonicity agent
12/16/2010WO2010142030A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
12/16/2010WO2010141986A1 Novel antibodies and uses therefor
12/16/2010WO2010096470A3 Method for inhibiting neurodegeneration
12/16/2010WO2010089411A3 Pd-1 antibodies and pd-l1 antibodies and uses thereof
12/16/2010WO2010065072A8 Antagonists of il-6 to raise albumin and/or lower crp
12/16/2010US20100319073 GDE Compositions and Methods
12/16/2010US20100317592 Chemokine-binding protein and methods of use
12/16/2010US20100317026 VMP-Like Sequences Of Pathogenic Borrelia
12/16/2010US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9
12/16/2010US20100316994 Diagnosis and therapy of cancer using sgp28-related molecules
12/16/2010US20100316724 Composition
12/16/2010US20100316723 Compositions and methods for treating inflammation
12/16/2010US20100316715 Chitosan composition
12/16/2010US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/16/2010US20100316697 Methods and compositions for drug targeting
12/16/2010US20100316675 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
12/16/2010US20100316674 Immunogenic compositions against tuberculosis
12/16/2010US20100316673 Nanoemulsion vaccines
12/16/2010US20100316672 Vaccine
12/16/2010US20100316671 Monoparamunity inducers based on attenuated rabbit myxomaviruses
12/16/2010US20100316670 Chimeric sle/dengue type 4 antigenic viruses
12/16/2010US20100316669 Vaccine formulation potentiated by the combination of dna and an antigen
12/16/2010US20100316668 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 1823